Dopavision Appoints Prof. Dr. Jens Ellrich as Chief Scientific Officer
21 mars 2023 05h00 HE | AKAMPION
- Leading translational medicine and neuroscience expert to head Dopavision’s research activities Berlin, Germany, March 21, 2023 --- Dopavision, a clinical-stage company pioneering the...
logo color s and clearside.jpg
Clearside Biomedical Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
09 mars 2023 16h05 HE | Clearside Biomedical, Inc.
- Initiation of Phase 2b ODYSSEY Trial of CLS-AX in Wet AMD Expected in Q2 2023 - - Medical Meeting Presentations Highlight Significant Potential of CLS-AX Based on Positive OASIS Phase 1/2a Safety...
ONL logo.jpg
ONL Therapeutics Closes First Tranche of $15 Million Series C Financing to Advance Lead Compound into Phase 2 Clinical Trial
08 mars 2023 07h00 HE | ONL Therapeutics
ANN ARBOR, Mich., March 08, 2023 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal...
Oculis Announces US Public Listing on NASDAQ
03 mars 2023 07h00 HE | Oculis
Oculis Announces US Public Listing on NASDAQ Closing of business combination with European Biotech Acquisition Corp. creates Nasdaq-listed ophthalmology company, under the ticker “OCS”, with advanced...
Global Fundus Camera Market
Fundus Camera Global Market Report 2023: Increasing Number of Product Launches by Key Players is Expected to Propel Growth
01 mars 2023 09h48 HE | Research and Markets
Dublin, March 01, 2023 (GLOBE NEWSWIRE) -- The "Fundus Camera Market, by Product Type, by Modality, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030" report...
logo color s and clearside.jpg
Clearside Biomedical to Report Fourth Quarter and Full Year 2022 Financial Results and Provide Corporate Update on Thursday, March 9, 2023
23 févr. 2023 07h05 HE | Clearside Biomedical, Inc.
ALPHARETTA, Ga., Feb. 23, 2023 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the...
Amniotic Membrane Market Size Report ($2.80 Billion by 2028) Lead by Cryopreserved Amniotic Membrane Segment – Exclusive Report by The Insight Partners
21 févr. 2023 08h08 HE | The Insight Partners
New York, Feb. 21, 2023 (GLOBE NEWSWIRE) -- According to The Insight Partners, “Amniotic Membrane Market Size, Share, Growth, Trends and Global Forecast to 2028 - COVID-19 Impact and Global Analysis...
Full Logo - OKYO .jpg
OKYO Pharma to Present at the Second Annual GPCRs-Targeted Drug Discovery Summit in Boston, MA on February 21-23, 2023.
21 févr. 2023 07h00 HE | OKYO Pharma LTD
LONDON and NEW YORK, Feb. 21, 2023 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (LSE: OKYO; NASDAQ: OKYO) (“OKYO”, “OKYO Pharma” or the “Company”), an ophthalmology-focused bio-pharmaceutical company...
IQ Laser Vision Rowland Heights Celebration
IQ Laser Vision Celebrates Opening of New Rowland Heights Location
16 févr. 2023 13h00 HE | IQ Laser Vision
ROWLAND HEIGHTS, Calif., Feb. 16, 2023 (GLOBE NEWSWIRE) -- IQ Laser Vision, the leader in providing clear vision to clients throughout California and Houston, Texas, is proud to announce the grand...
Frontera Therapeutics Doses First Patient in a Trial of FT-002 Gene Therapy for the Treatment of X-Linked Retinitis Pigmentosa
16 févr. 2023 08h00 HE | Frontera Therapeutics
BEDFORD, Mass. and SHANGHAI, China, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Frontera Therapeutics, a global clinical-stage biotechnology company that seeks to develop novel and best-in-class gene therapy...